Petauri™ Announces Expanded Leadership Role for William Fleming, PharmD

Rapidly growing pharmaceutical services platform welcomes long-time industry executive as Senior Advisor, expanding leadership role beyond Board of Directors

NASHVILLE, Tenn., March 5, 2025 /PRNewswire/ — Petauri, a leading purpose-built pharmaceutical services platform, is pleased to announce that William Fleming, PharmD, has expanded his role within the company, joining as a Senior Advisor in addition to continuing as a Board Member. Dr. Fleming’s deep expertise in healthcare innovation and strategy will further strengthen Petauri’s mission to drive transformative solutions for pharmaceutical and life sciences innovators, US payers, health systems, providers, and patients.

A respected healthcare leader, Dr. Fleming brings decades of experience in pharmacy, healthcare services, and benefits administration. His leadership at Humana, where he spent more than 30 years in various executive roles, has shaped innovative approaches to health and benefits delivery along with formulary access and reimbursement.

“We are thrilled to have William take on this expanded role as a Senior Advisor,” said Dan Renick, CEO of Petauri. “His extensive industry knowledge, strategic vision, and passion for improving healthcare access and affordability make him an invaluable asset to our leadership team. As we continue to grow and evolve, his insights will be instrumental in shaping our strategy and delivering even greater value to our clients.”

Fleming expressed enthusiasm for his increased engagement with Petauri. “I have long admired Petauri’s commitment to innovation and simplifying the complexities of healthcare, especially in matters of value demonstration, access, reimbursement, and scientific communications,” said Fleming. “I look forward to working even more closely with Dan and the exceptional Petauri team to help drive meaningful solutions that make a difference for clients and their many partners across the healthcare ecosystem, all in support of improving patient outcomes.”

Petauri remains committed to leveraging industry-leading expertise to develop cutting-edge technology and service solutions that enhance healthcare experiences and patient outcomes. Dr. Fleming’s expanded role reinforces the company’s dedication to strong leadership, strategic growth, and meaningful improvements in clinical and economic value demonstration.

About Petauri
Petauri is a purpose-built pharmaceutical services platform based in Nashville, Tennessee. Founded by CEO Dan Renick in partnership with Oak Hill Capital, the platform is launching, acquiring, and combining best-in-class companies with recognized expertise in global market access, medical affairs, commercialization support, patient services, and data and analytics. Since it was founded in 2023, the platform has launched Petauri Advisors and acquired The Kinetix Group, the agencies of FORCE Communications, Mtech Access, Delta Hat, the agencies of the Brightly Network, and Formulary Insights, all now Powered by Petauri™. Over time, Oak Hill will invest more than $250 million of equity capital in this initiative from its latest fund (OHCP VI). The platform works with pharmaceutical and life sciences clients to improve patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances. From strategy to implementation, Petauri seamlessly supports these clients with a wide range of innovative solutions that speed patient access to life-changing care. For more information, please visit www.petauri.com.

Media Contact:
Liz Gulino
Petauri
Liz.Gulino@petauri.com
(973) 476-1751

View original content to download multimedia:https://www.prnewswire.com/news-releases/petauri-announces-expanded-leadership-role-for-william-fleming-pharmd-302392467.html

SOURCE Petauri